Following a significant leap adhering to the discharge of OpenAI’s new GPT-4o “omni” product, the cellular version of ChatGPT has now found its greatest month of earnings yet.An April 2023 examine in Radiology examined the AI's ability to solution queries about breast cancer screening. The authors identified that it answered properly "about 8